Tubulin binding anti cancer agents and prodrugs thereof

Details for Australian Patent Application No. 2005309761 (hide)

Owner Threshold Pharmaceuticals, Inc.

Inventors Duan, Jian-Xin; Cai, Xiaohong; Matteucci, Mark

Agent Spruson & Ferguson

Pub. Number AU-A-2005309761

PCT Pub. Number WO2006/057946

Priority 60/726,928 14.10.05 US; 60/630,422 22.11.04 US

Filing date 17 November 2005

Wipo publication date 1 June 2006

International Classifications

A61K 31/4745 (2006.01)

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/057946 Priority application(s): WO2006/057946

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309765-4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin

2005309760-2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease